Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China · Delayed Price · Currency is CNY 27.11
+0.14 (0.52%)
At close: Apr 30, 2026
6.86% (1Y)
| Market Cap | 2.74B +5.6% |
| Revenue (ttm) | 879.60M +6.6% |
| Net Income | 48.14M +6.1% |
| EPS | 0.46 +2.7% |
| Shares Out | 101.08M |
| PE Ratio | 58.48 |
| Forward PE | n/a |
| Dividend | 0.35 (1.30%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 1,325,252 |
| Average Volume | 1,180,792 |
| Open | 27.10 |
| Previous Close | 26.97 |
| Day's Range | 26.67 - 27.22 |
| 52-Week Range | 24.10 - 39.66 |
| Beta | 0.65 |
| RSI | 54.11 |
| Earnings Date | Apr 27, 2026 |